MACS

What MACS does

MACS s.r.l. (legal name MACS s.r.l., trade name "Medical Advanced Component Systems") is a privately held Italian limited liability company headquartered in Rome that develops hardware and software technologies for medical diagnostic devices, with a stated specialization in in vitro diagnostics (IVD) and biomedical instrumentation spanning biotechnology, computer science, and automation. The company's product portfolio is anchored by SkyLAB 752, an automated platform for ELISA/EIA methods and IFA immunofluorescence slides designed for high-workload clinical laboratories, with built-in barcode-based resource identification for intrinsically safe operation. Layered on top of this instrument are VitroCERT, a proprietary image-processing and pattern-recognition technology with AI algorithms for real-time certification of diagnostic results, and the IGRA Automation module, a dedicated application for automated Interferon-Gamma Release Assay (tuberculosis) testing on 96-well microplates. A separate POCT (point-of-care) product line includes the co-developed "easy TOX" cup reader for drugs-of-abuse testing.

MACS monetizes primarily through one-time product sales, OEM white-label arrangements, and co-development partnerships. SkyLAB 752 is distributed globally by three channel partners - DASIT, SCLAVO, and ADALTIS - the last of which sells it under the NexGEN brand as an OEM/white-label partner; the platform is reported as present in 30+ countries and holds CE mark, FDA, and SFDA certifications. Beyond hardware, MACS offers custom embedded software for medical devices and standalone Software as a Medical Device (SaMD) under agile development processes, targeting IVD manufacturers and clinical-laboratory operators. The company has no disclosed funding history, no parent corporate structure, no public ownership, and no revenue disclosure; growth signals are limited to dated product launches (easy TOX in October 2022, Liquid Biopsy pre-analytical platform with TETHIS in June 2022, IGRA Automation in 2019) and active participation in international industry events (Medlab Middle East 2021, MATCHES 2022).

Name

MACS

Legal name

MACS s.r.l.

Website

https://macs-srl.it

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

MACS s.r.l. is a privately held Italian company that develops hardware and software technologies for medical diagnostic devices, specializing in in vitro diagnostics; it sells the automated SkyLAB 752 immunoassay platform through OEM and channel partners (DASIT, SCLAVO, ADALTIS) and offers proprietary AI-based VitroCERT certification, IGRA, and POCT products to clinical laboratories and IVD manufacturers worldwide.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics / Medical Diagnostic Equipment

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

akta.pro secondary industries

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN), Medical Imaging AI (HDAAAEAH), SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)

Keywords

• In vitro diagnostics
• Immunoassay systems
• Medical diagnostic devices
• ELISA automation
• Biomedical instrumentation

Headquarters

HQ city

Roma

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Medical Diagnostic Hardware and Software Products: MACS develops and sells advanced components and systems for biomedical instrumentation, including the SkyLAB 752 platform, VitroCERT certification technology, and IGRA automation solutions. Revenue is generated through product sales, OEM partnerships, and distribution agreements with medical diagnostic companies.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

MACS develops and sells hardware and software technologies for medical diagnostic devices with specialization in in vitro diagnostics (IVD). Its core product is the SkyLAB 752 automated immunoassay platform for ELISA/EIA and IFA immunofluorescence testing, complemented by proprietary VitroCERT AI/image-processing certification technology, IGRA automation for tuberculosis testing, and POCT solutions including the easy TOX cup reader for drugs of abuse. The company also delivers embedded software and Software as a Medical Device (SaMD) tailored to client needs.

Product overview

MACS offers a portfolio of hardware and software technologies for medical diagnostic devices specializing in in vitro diagnostics (IVD). The core product is SkyLAB 752, an automatic immunoassay platform supporting ELISA/EIA methods and IFA immunofluorescence, which serves as the foundation for the IGRA Automation module for tuberculosis testing. VitroCERT provides proprietary image processing and AI-based certification of diagnostic results to prevent false results in IVD equipment. The POCT product line includes easy TOX, the first fully automatic POCT cup reader made in Italy developed in partnership with IVY Diagnostics. The company also offers embedded software development and Software as a Medical Device (SaMD) solutions tailored to client needs.

Differentiator

Problem solved

Functional benefit

Brands

• SkyLAB 752: Automatic platform for ELISA/EIA methods and IFA immunofluorescence slides, distributed by DASIT, SCLAVO and ADALTIS (OEM with NexGEN brand). Has obtained CE mark, FDA, and SFDA certifications.
• VitroCERT
• IGRA AUTOMATION
• POCT

Products and services

• SkyLAB 752 Immunoassay System An automatic platform for ELISA/EIA methods and IFA immunofluorescence slides designed for large workloads in clinical laboratories. Every resource is automatically identified using barcodes, making it an intrinsically safe system. Present in 30+ countries through OEM distributors.
• VitroCERT Proprietary technology for the certification of diagnostic results in IVD equipment. Uses advanced image processing, pattern recognition algorithms, and AI executed on high-performance, low-energy hardware to provide real-time control of effective dispensing of sera and reagents, preventing false negatives or false results.
• IGRA Automation Dedicated application on the SkyLAB 752 platform for IGRA (Interferon-Gamma Release Assay) testing, enabling full automated processing of ELISA tests on 96-well microplates for detection of IFN-gamma produced by T-lymphocytes (primarily for tuberculosis diagnosis). Includes dedicated Management Software for data management and patient report elaboration.
• POCT (Point of Care Testing) — easy TOX Point of Care Testing product line. The easy TOX POCT is the first fully automatic cup reader made in Italy for drugs of abuse testing, developed in collaboration with IVY Diagnostics.

Quantifiable outcome

• SkyLAB 752 is present in 30+ countries

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• IVY DiagnosticscoreStrategic or Co-development Partner · 13 October 2022Collaboration between IVY Diagnostics and MACS resulted in easy TOX™, the first POCT made in Italy - a fully automatic cup reader for abuse drugs. This represents joint product development in the point-of-care testing space.
• TETHIScoreStrategic or Co-development Partner · 16 June 2022MACS and TETHIS collaborated to launch the first automatic pre-analytical platform for Liquid Biopsy testing during the EACR conference in Bergamo (May 24-26, 2022). This is a co-development partnership for innovative diagnostic solutions.
• DASITcoreChannel Partner/ Reseller/ DistributorDASIT distributes the SkyLAB 752 immunoassay system as a channel partner, helping MACS reach clinical laboratory customers in their distribution regions.
• SCLAVOcoreChannel Partner/ Reseller/ DistributorSCLAVO distributes the SkyLAB 752 immunoassay system as a channel partner, extending MACS's reach into additional market segments.
• ADALTIScoreOEM/ Whitelabel/ Licensing PartnerADALTIS distributes SkyLAB 752 under the NexGEN brand as an OEM partner, enabling white-label distribution of MACS's technology.
• Bureau VeritasminorOthersBureau Veritas certification partner, as indicated by their logo on the MACS website footer.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ADALTIS: IVD instrument company that white-labels SkyLAB 752 as NexGEN. Operates in the same IVD equipment market and is both a partner and a near-adjacent competitor in immunoassay analyzers.
• STRATEC SE: German OEM partner that designs and manufactures fully automated analyzer systems for IVD and life sciences companies. Closely parallels MACS's OEM business model of building analyzers sold under partners' brands (e.g., NexGEN via ADALTIS).
• Dynex Technologies: Manufacturer of automated ELISA processing systems (DSX, DS2) used in clinical and research laboratories. Directly competes with MACS's SkyLAB 752 in the automated immunoassay/ELISA workflow.
• DASIT S.p.A. Italian IVD distributor and manufacturer that is also SkyLAB 752's principal distribution partner. Operates in the same clinical immunoassay and IVD space with overlapping customer base in Italy and Europe.
• Tecan Group: Swiss leader in laboratory automation and OEM components for IVD instrument manufacturers. Highly comparable to MACS in serving diagnostics OEMs with embedded hardware/software and laboratory automation platforms.
• Hamilton Company: Provides automated liquid handling and ELISA processing platforms for clinical diagnostics and life sciences. Comparable in lab automation focus and OEM-style deployments for diagnostic workflows.

Broad incumbents

• Mindray: Major Chinese IVD and medical device company with chemiluminescence immunoassay analyzers and clinical chemistry systems. Operates broadly in the same IVD/instrument space as MACS.
• Bio-Rad Laboratories: Large established IVD and life science company with broad immunoassay, ELISA, and clinical diagnostics portfolio. Competes with SkyLAB 752 as part of a much wider product set.
• Abbott Diagnostics: Global IVD incumbent with extensive immunoassay and clinical chemistry platforms. Defines the competitive landscape MACS operates in, even though it does not directly target MACS's niche.

Emerging players

• Quanterix: Emerging diagnostics player using proprietary single-molecule and AI-driven detection for biomarker measurement. Comparable in leveraging advanced algorithms to add diagnostic value beyond conventional immunoassay, though focused on neuro and specialty biomarkers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/macs.srl
• LinkedInlinkedin.com/company/macs-srl

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MACS